drugset / Trial / NCT04334382
Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19
Phase 3
Unknown
1550 enrolled
Intermountain Health Care, Inc.
University of Utah · collabUtah Department of Health · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will compare two drugs (hydroxychloroquine and azithromycin) to see if hydroxychloroquine is better than azithromycin in treating outpatients with suspected or confirmed COVID-19.
Timeline
- Start
- 2020-04-02
- Primary completion
- 2020-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 250 mg | Oral |
| Subject | Hydroxychloroquine | Small molecule | 200 mg | Oral |